MET (MetLife) Other Financing: $7,568 Mil (TTM As of Mar. 2026)


MET MetLife Inc MET
76 GF Score
Price $85.72
GF Value $89.60
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is MetLife Other Financing?

MetLife MET -0.27% 76 Other Financing is $7,568 Mil as of Mar. 2026. GuruFocus rates MET with a GF Score™ of 76/100 and a GF Value™ of $89.60 (Fairly Valued). The stock has 8 warning signs investors should review.

MetLife's Other Financing for the three months ended in Mar. 2026 was $4,103 Mil.

MetLife's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $7,568 Mil.

MetLife Other Financing Historical Data

* Premium members only.

The historical data trend for MetLife's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetLife Other Financing Chart

MetLife Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,072.00 -5,767.00 1,136.00 2,624.00 6,191.00

MetLife Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,726.00 1,900.00 647.00 918.00 4,103.00
MET
76GF Score
MetLife Inc MET
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MetLife Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $7,568 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $7,568 Mil mean?
MetLife (MET) has a Other Financing of $7,568 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for MetLife and its competitors.
Is MetLife's Other Financing too high?
MetLife's current Other Financing is $7,568 Mil. Overall, MetLife has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MetLife's Other Financing compare to AFL and PRU?
MetLife's Other Financing of $7,568 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for an Insurance company?
A good Other Financing depends on the Insurance industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for MetLife and its competitors. MetLife's current Other Financing is $7,568 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetLife stock overvalued right now?
Based on GuruFocus' analysis, MetLife (MET) is currently considered Fairly Valued. The stock's GF Value™ is $89.60, compared to a current price of $85.72 — trading 4.3% below its estimated fair value. The current Other Financing is $7,568 Mil. MetLife's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For MetLife (MET), the current Other Financing is $7,568 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MetLife (MET) Overvalued in 2026?

Based on GuruFocus' analysis, MetLife stock appears to be undervalued. The current stock price of $85.72 is trading 4.3% below its estimated GF Value™ of $89.60. GuruFocus considers MetLife to be Fairly Valued.

Key valuation signals for MET:

  • Other Financing: $7,568 Mil
  • GF Value™: $89.60 vs. price of $85.72 (4.3% below fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the MET stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MetLife Business Description

Address 200 Park Avenue, New York, NY, USA, 10166-0188
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
76GF Score

Get the complete analysis for MET

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$85.72
Price
$89.60
GF Value